1. A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment
   Paulina Pilanc et al, 2021, Front. Oncol. CrossRef
2. Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
   Ying Lu et al, 2022, Front. Oncol. CrossRef